5 Fantastic Monthly Magazines, hitting over 50,000 homes & businesses across Cheshire – Affordable, EFFECTIVE advertising, our readers love them so will you!
Welcome to Day 1 of #AMMF’s Hybrid 2024 European #Cholangiocarcinoma Conference in London! We are proud to host an array of global speakers who will share insights into cutting-edge topics in CCA.
Register for virtual attendance: ammf.org.uk/ammf-conference-…#AMMF2024
We are ready and looking forward to welcoming our guests tomorrow at #AMMF’s Hybrid 2024 European Cholangiocarcinoma Conference. Not signed up yet and want to attend? There is still time to join us! To sign up visit: ammf.org.uk/ammf-conference-…#bileductcancer#AMMF2024
#AMMF believes it’s time to #RethinkLiverCancer.
At Westminster today, we share new data and recommendations that highlight the growing threat from this little-known disease with one of the worst survival rates of any cancer.
#bileductcancer#cholangiocarcinoma
On 20 February #AMMF’s House of Commons reception introduces our #RethinkLiver Cancer White Paper, calling for a better understanding, diagnosis and treatment of #cholangiocarcinoma, based on our 4yr NHS data study of over 50,000 patients: rb.gy/qlc8t8#bileductcancer
#AMMF is proud to mark this year’s World CCA Day. Join us to hear about the latest advances in CCA research, diagnosis, healthcare and more at AMMF’s Hybrid 2024 European #Cholangiocarcinoma Conference in London.
Register today: ammf.org.uk/ammf-conference-…#WorldCCADay
Hundreds of people could be set to benefit after final guidance was published today recommending a new first-line treatment for advanced biliary tract cancer.
Find out more: nice.org.uk/guidance/TA944/h…#NICENews
ALT Graphic showing photo of healthcare professional and the following text: Just over 700 people could benefit after durvalumab, in combination with gemcitabine and cisplatin, was recommended to treat advanced biliary tract cancer.
The 5-year survival rate across all cancers in England is 54%, #AMMF data show 6-9% for CCA & 2% for late stage diagnosis. It’s time to #RethinkLiverCancerto improve early detection & survival for this devastating primary liver cancer. ow.ly/Bzli50PTP0x#livertwitt…